Education
About Us
Working with TipRanks
Follow Us
Stelios Papadopoulos Insider Profile
4 Followers
Stelios Papadopoulos, Director at Exelixis, holds 0.00 shares in Regulus (Ticker: RGLS), holds 1.29M shares in Exelixis (Ticker: EXEL), holds 38.30K shares in Biogen (Ticker: BIIB).
Profitable Transactions
9 out of 20 Profitable Transactions
Average Return
-16.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Stelios Papadopoulos holds in companies
Most Profitable Insider Trade
The most profitable trade made by Stelios Papadopoulos
Stelios Papadopoulos's Trading History
Exelixis
May 30, 2025
Director
Uninformative Buy
―
$49.65M
Biogen
Jun 17, 2022
Director
Uninformative Buy
―
$5.22M
Regulus
Jun 27, 2025
―
Uninformative Sell
―
$0.00
GenVec Inc
―
―
―
$2.20M
BG Medicine
Feb 01, 2013
Director
Informative Buy
500.00K
―
List of latest transactions for each holding click on a transaction to see Stelios Papadopoulos's performance on stock
You May Also Like
Stelios Papadopoulos insider profile FAQ
What is the percentage of profitable transactions made by Stelios Papadopoulos?
The percentage of profitable transactions made by Stelios Papadopoulos is 45%.
What is the average return per transaction made by Stelios Papadopoulos?
The average return per transaction made by Stelios Papadopoulos is -16.30%.
What stocks does Stelios Papadopoulos hold?
Stelios Papadopoulos holds: EXEL, BIIB, RGLS, GNVC, BGMD stocks.
What was Stelios Papadopoulos’s latest transaction?
Stelios Papadopoulos latest transaction was an Uninformative Sell of ―.
What was Stelios Papadopoulos's most profitable transaction?
Stelios Papadopoulos’s most profitable transaction was an Informative Sell of EXEL stock on September 20, 2017. The return on the trade was 40.20%.
What is Stelios Papadopoulos's role in Exelixis?
Stelios Papadopoulos's role in Exelixis is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.